Investing in ways to address social risk factors and health disparities related to treatments for burdensome conditions has become a critical component of advancing health equity in the US healthcare system. The foundation of understanding these treatment outcome inequities and of closing healthcare gaps is real-world evidence (RWE) generation and health economics and outcomes research (HEOR). This webinar will focus on how integrating social determinants of health (SDOH) data with claims-based research can provide an opportunity to improve treatment access and outcomes for under-represented populations through targeted research and strategic efforts.
Presenters:
- Christie Teigland, PhD, Vice President, Research Science and Advanced Analytics, Inovalon, Bowie, MD, USA
- Alexandra Ehrlich, MPH, Senior Director, Sales Engineering, Inovalon, Bowie, MD, USA
- Allison Petrilla, MPH, Vice President, HEOR, Inovalon, Bowie, MD, USA
Related Content
Improving Patient Outcomes: AI-Based Phenotyping for Diagnosis, Treatment, and Clinical Trials
Join a panel of OM1’s clinical experts in cardiometabolic disease, immunology, and mental health as they explore how Artificial Intelligence (AI) can find phenotypic patterns and unlock insights hidden in real-world data.
Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases
Watch this webinar exploring real challenges and solutions for generating patient-centered real-world evidence (RWE) in the context of rare diseases to support clinical development through commercial post-approval.
The role of patient-centric technologies & tokenization in RWE studies
Join the Castor team on the 3rd May 2023 with Aaron Berger from UBC & Ryan Moog from Datavant where we will dive deep into all things RWE, patient-centric technologies and the role of tokenization in clinical trials. You will hear about RWE case studies from the experts, learn new trends in the adoption of DCTs and how the role of patient-centric technologies & tokenization can contribute to successful RWE studies.